Loading...
  • coronary stent
  • A sirolimus eluting coronary stent is marketed by Cordis, a division of Johnson & Johnson , under the tradename Cypher . (wikidoc.org)
  • BRIDGEWATER, N.J., June 15, 2011 /PRNewswire-FirstCall/ -- Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced it will no longer pursue the development of the NEVO™ Sirolimus-Eluting Coronary Stent in order to focus on other cardiovascular therapies where significant patient need exists. (mdtmag.com)
  • patients
  • Several large clinical studies have demonstrated lower restenosis rates in patients treated with sirolimus eluting stents when compared to bare metal stents, resulting in fewer repeat procedures. (wikidoc.org)
  • The purpose of this study is to find out about the safety and effectiveness of the study drug, sirolimus, in patients with uveitis and to utilize the potential effectiveness of sirolimus, and yet to avoid the potential complications of systemic use of the drug. (clinicaltrials.gov)
  • The study compared central subfield thickness data of patients who received monotherapy sirolimus versus those who continued with their current anti-VEGF regimen. (eyetube.net)
  • All patients will be open-label, Sirolimus. (clinicaltrials.gov)
  • This study will determine whether a drug called sirolimus is safe to give to people with geographic atrophy (GA) and if it can help preserve vision in patients. (clinicaltrials.gov)
  • bioresorbable
  • Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial. (terumo-europe.com)
  • MOUNTAIN VIEW, CA , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical , a privately held medical device company, announced the initiation of a clinical study of the Company's latest-generation MAGNITUDE™ sirolimus-eluting bioresorbable scaffold (BRS) scaffold, which has a strut thickness in the sub-100-micron range. (cnbc.com)
  • stents
  • The anti-proliferative effect of sirolimus has also been used in conjunction with coronary stents to prevent restenosis in coronary arteries following balloon angioplasty. (wikidoc.org)
  • The company will also stop the manufacture of CYPHER® and CYPHER SELECT® Plus Sirolimus-Eluting Coronary Stents by the end of 2011. (mdtmag.com)
  • liver
  • The purpose of this study is to evaluate the effectiveness and safety of Sirolimus in reducing liver volume in autosomal dominant polycystic kidney disease. (clinicaltrials.gov)
  • Intervention
  • The sirolimus is formulated in a polymer coating that affords controlled release through the healing period following coronary intervention. (wikidoc.org)
  • ounces
  • Sirolimus oral liquid must be mixed in a glass or plastic cup with at least 2 ounces (1/4 cup) of water or orange juice. (cigna.com)
  • elderly
  • Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of sirolimus in the elderly. (drugs.com)